Denial rates hit an average of 12% across U.S. healthcare organizations in 2025 — and hospitals lost more than $48 billion to final denials and bad debt that year alone, a 25% increase over 2024. [Kodiak Solutions, Revenue Cycle Analytics Benchmarking, March 2026] Health systems already spend 3–4% of revenue just running their revenue cycle. [McKinsey, "Agentic AI: The Race to a Touchless Revenue Cycle," January 2026] The administrative burden isn't shrinking. The question is whether your AI investment is built to actually reverse these numbers — or just add another dashboard to ignore.

The organizations getting measurable results from RCM AI share five priorities. Here's what they're doing differently.

1. Demand RCM Expertise Behind the AI, Not Just AI Credentials

The AI market in healthcare has never been more crowded. That's a selection risk, not a windfall. Vendors competing on capability claims are difficult to evaluate before you're already mid-implementation — and by then, the cost of switching is high.

What separates high-performing deployments from expensive experiments is domain depth: does the vendor understand payer-specific adjudication logic, EDI transaction workflows, prior authorization triggers, and the operational reality of a billing team under pressure? General-purpose automation applied to RCM problems produces general results. Purpose-built AI trained on healthcare-specific data — claim patterns, payer behavior, denial root causes — produces revenue.

63% of healthcare organizations had already integrated AI-powered automation into their revenue cycle by late 2024, according to an HFMA/FinThrive survey. [HFMA, "Most Healthcare Organizations Are Adopting AI in the Revenue Cycle," May 2025] The institutions outperforming that cohort are the ones that selected partners with demonstrated RCM depth, not the ones that adopted AI first.

Black Book Research found that 83% of organizations using AI-driven automation reduced claim denials by at least 10% within the first six months. [Black Book Research, "AI in Healthcare Finance: 2025 Market Review," February 2025] That result doesn't come from AI alone — it comes from AI that understands why claims deny in the first place.

ENTER's platform is built on this premise. The AI covers eligibility verification, prior authorization tracking, claim scrubbing, payment posting, and denial pattern analysis — with domain specificity that treats payer behavior as a data problem, not a manual follow-up task.

2. Security Is a Prerequisite, Not a Feature

The Change Healthcare ransomware attack in February 2024 exposed the protected health information of an estimated 190 million individuals — the single largest healthcare data breach on record. [HIPAA Journal, "The Biggest Healthcare Data Breaches of 2024," March 2025] Total breached healthcare records in 2024 reached approximately 277 million, a 64% increase over the prior year. [HIPAA Journal]

The lesson from that breach is not to slow AI adoption. It's to raise the bar on which vendors you trust with workflows that touch PHI. Healthcare organizations that responded by tightening vendor security requirements, not by pulling back on technology, are the ones positioned to move faster now.

Evaluate AI platforms on their security architecture — not their security marketing. SOC 2 Type II certification, HIPAA Business Associate Agreements that reflect actual data handling practices, infrastructure-level data minimization, and transparent incident disclosure policies are the floor. The Change Healthcare incident demonstrated that your exposure isn't just your own — it extends to every vendor in your workflow that handles patient data at scale.

ENTER's platform is built with HIPAA compliance and data minimization embedded at the infrastructure level. PHI handling is governed by contractual controls that match operational reality, not legal boilerplate.

3. Apply AI Where It Creates Targeted, Measurable Impact

Organizations that deploy AI broadly — across every workflow simultaneously — tend to produce diffuse results that are hard to attribute and harder to defend at budget review. The organizations seeing the largest ROI are those that define high-friction, high-cost problems first, then select the tool.

In 2025, denial management and appeals were the top AI investment priority for 57% of revenue cycle leaders, followed by documentation and coding accuracy at 56%. [McKinsey, "Healthcare Revenue Cycle Management at a Strategic Turning Point," 2025] Those two functions are the right place to start — they're where billing errors compound, staff time disappears, and revenue leakage is easiest to measure.

The math on front-end prevention is straightforward. Every eligibility miss that isn't caught before service becomes a denial that costs $25–$118 to rework. [MGMA] Catch it upstream with AI-driven verification, and the rework cost disappears entirely. Organizations leveraging automation in patient financial services reported 30% higher productivity and 20% lower turnover. [Becker's Hospital Review] The operational case isn't abstract.

The prioritization question should drive the implementation sequence: Where in your revenue cycle is the highest density of preventable errors? Where is staff time being consumed by tasks a model could handle in seconds? Start there, measure against a clear baseline, and build outward from proven results.

ENTER's AI concentrates on exactly these points of highest leverage: real-time eligibility, prior auth status tracking, pre-submission claim scrubbing, and denial root-cause analysis that surfaces the upstream patterns generating downstream losses.

4. Consolidate to a Platform — Point Solutions Are a Liability

Fragmented RCM systems don't just create IT complexity — they create revenue loss. When eligibility data, claim management, payment posting, and denial analytics operate in separate systems, information gaps are inevitable. Those gaps produce inconsistencies. Those inconsistencies produce billing errors. Those errors produce denials. And your team spends its capacity on reconciliation instead of collections.

Health systems collectively spend more than $140 billion annually running their revenue cycle, with fragmented vendor landscapes identified as a primary cost driver alongside manual processes and outdated technology. [McKinsey, January 2026] That fragmentation isn't just a cost problem. It's a data integrity problem that directly limits how effectively AI can function — models that can't access complete, connected data across the full revenue cycle produce incomplete, disconnected results.

A consolidated platform unifies your data model across eligibility, claims, payments, and denial management. It enables longitudinal analytics that track denial root causes across months of claims history — the kind of pattern recognition that point solutions simply can't support. It also simplifies HIPAA compliance, reduces vendor management overhead, and makes performance reporting coherent instead of fragmented across dashboards that don't talk to each other.

ENTER is built as a unified platform — eligibility, claim submission, payment posting, and denial management operating from a single data model, with native EMR integration via HL7/FHIR and direct payer connectivity that eliminates the clearinghouse markup.

5. Require Documented Proof — ROI Is the Minimum Standard, Not the Goal

The healthcare industry spent years absorbing AI pilots that produced impressive demos and underwhelming financials. The bar has moved. Revenue cycle leaders now enter vendor conversations with measurable ROI as a non-negotiable requirement, not a nice-to-have.

McKinsey projects that AI and automation in the revenue cycle can reduce cost-to-collect by 30–60%. [McKinsey, "Agentic AI: The Race to a Touchless Revenue Cycle," January 2026] Black Book Research found that 68% of RCM executives reported AI improved net collections, with 39% seeing more than a 10% increase in cash flow within six months of implementation. [Black Book Research, February 2025] These are operational results from running organizations — not projections from vendor-sponsored studies.

The question to ask any AI vendor is not "what can your platform do?" It's: "What has it produced, for which type of practice, measured against which baseline, at what implementation timeline?" Require documented performance benchmarks at 90 and 180 days post-go-live. Require a commitment to the metrics that actually matter: clean claim rate, first-pass resolution rate, days in A/R, denial rate by payer, and net collection rate.

If a vendor can't answer those questions with specifics, that's the answer.

Key Takeaways

Five things that separate organizations extracting real value from RCM AI from those still waiting for it:

RCM-specific AI outperforms general-purpose automation — domain expertise is the differentiator, not AI sophistication in the abstract. Security architecture matters more than security certifications — evaluate how PHI is actually handled, not how it's marketed. Targeted deployment beats broad rollout — define the problem and the success metric before selecting the tool. Platform consolidation is a data integrity decision as much as a cost decision — fragmented systems limit what AI can do. Require documented, operational results with specific metrics and timelines — not benchmarks from atypical organizations or vendor-sponsored research.

FAQ

What makes AI effective in healthcare revenue cycle management?

Effectiveness in RCM AI comes from domain specificity. Models trained on healthcare-specific payer data, claim structures, and adjudication logic outperform general-purpose automation applied to billing workflows. The domain depth behind the model — not AI sophistication in the abstract — determines whether an implementation reduces denials or generates rework. Measurable benchmarks established before deployment are what separate productive implementations from expensive ones.

How does AI reduce claim denials?

AI reduces denials by catching errors and coverage issues before claims are submitted. Real-time eligibility verification, prior authorization tracking, and pre-submission claim scrubbing identify upstream conditions — incorrect patient data, missing authorizations, coverage gaps — that are responsible for the majority of front-end denials. Black Book Research found that 83% of organizations using AI-driven automation reduced claim denials by at least 10% within the first six months. Catching these issues upstream eliminates the rework cost entirely.

Why is platform consolidation important for RCM AI?

Point solutions in the revenue cycle create data gaps between systems. Those gaps produce billing errors, reconciliation failures, and denial blind spots. Consolidated platforms share a single data model across eligibility, claims, payments, and denial management — enabling the longitudinal analytics and AI pattern recognition that require complete, connected data to function accurately. McKinsey identifies fragmented vendor landscapes as one of the primary cost drivers in healthcare revenue cycle operations.

What security standards should I require from an AI-powered RCM vendor?

At minimum: SOC 2 Type II certification, a Business Associate Agreement that reflects actual PHI data handling, HIPAA-compliant infrastructure, and transparent policies on how patient data is used in model training. The 2024 Change Healthcare breach — which exposed the records of approximately 190 million individuals — demonstrated that vendor security posture directly affects your organization's exposure. Evaluate architecture and contractual controls, not marketing language.

How should organizations measure ROI from RCM AI?

Measure against the metrics the AI is built to move: clean claim rate, first-pass resolution rate, days in A/R, denial rate by payer, and net collection rate. Establish baseline measurements before implementation. Require your vendor to commit to measurable benchmarks at 90 and 180 days post-go-live. 68% of RCM executives report AI improved net collections; 39% saw more than a 10% increase in cash flow within six months. [Black Book Research, 2025] Those are the standards to hold your vendor to.

AI isn't a future-state investment for healthcare revenue cycle. It's operational infrastructure — and the organizations building it correctly are collecting more revenue with smaller teams. ENTER Health's platform is purpose-built for this work: a unified RCM AI that covers the full revenue cycle, integrates natively with your EMR, and is measured against the financial outcomes that matter. See what ENTER can do for your practice at enter.health.